Literature DB >> 9579324

Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration.

T E Robinson1, K E Browman, H S Crombag, A Badiani.   

Abstract

The conditions necessary to induce psychomotor sensitization and to promote its expression are not well understood. Two examples are reviewed here of how the circumstances surrounding drug administration ("set and setting") can powerfully modulate the sensitization produced by psychostimulant drugs, such as amphetamine or cocaine. In the first example it is suggested that repeated exposure to psychostimulant drugs may induce "neural sensitization" (i.e., produce relevant adaptations in the nervous system). The circumstances surrounding drug administration may determine, however, whether neural sensitization is expressed in behavior. In the second example it is suggested that the circumstances surrounding drug administration may determine whether sensitization is induced at all, or at least the rate and extent of sensitization produced by a given dose of a drug. It is concluded that psychomotor sensitization is not an inevitable consequence of exposure to psychostimulant drugs, but is the result of interactions amongst the pharmacological actions of drugs and the circumstances surrounding drug administration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579324     DOI: 10.1016/s0149-7634(97)00020-1

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  74 in total

Review 1.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 2.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

3.  Electrophysiological and structural alterations in striatum associated with behavioral sensitization to (±)3,4-methylenedioxymethamphetamine (Ecstasy) in rats: role of drug context.

Authors:  K T Ball; C L Wellman; B R Miller; G V Rebec
Journal:  Neuroscience       Date:  2010-09-25       Impact factor: 3.590

4.  Does context influence the duration of locomotor sensitization to ethanol in female DBA/2J mice?

Authors:  Stephen L Boehm; Karen J Goldfarb; Kristen M Serio; Eileen M Moore; David N Linsenbardt
Journal:  Psychopharmacology (Berl)       Date:  2007-11-30       Impact factor: 4.530

5.  Deletion of the 5-HT(3A)-receptor subunit blunts the induction of cocaine sensitization.

Authors:  C W Hodge; A M Bratt; S P Kelley
Journal:  Genes Brain Behav       Date:  2007-06-07       Impact factor: 3.449

6.  Associative Learning Drives the Formation of Silent Synapses in Neuronal Ensembles of the Nucleus Accumbens.

Authors:  Leslie R Whitaker; Paulo E Carneiro de Oliveira; Kylie B McPherson; Rebecca V Fallon; Cleopatra S Planeta; Antonello Bonci; Bruce T Hope
Journal:  Biol Psychiatry       Date:  2015-08-14       Impact factor: 13.382

7.  Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study.

Authors:  Joyce Colussi-Mas; Stefanie Geisler; Luc Zimmer; Daniel S Zahm; Anne Bérod
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

8.  Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm.

Authors:  Min Feng; Nan Sui; Ming Li
Journal:  Behav Brain Res       Date:  2012-10-23       Impact factor: 3.332

9.  Transient disruption of attentional performance following escalating amphetamine administration in rats.

Authors:  Robyn L Kondrad; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

10.  Effects of nicotine and stress exposure across generations in C57BL/6 mice.

Authors:  Nicole L Yohn; Michael J Caruso; Julie A Blendy
Journal:  Stress       Date:  2018-11-20       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.